KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyNet Income towards Common StockholdersNon Operating IncomeNon Operating Investment IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Ginkgo Bioworks Holdings (DNA) Shares Outstanding (Weighted Average) (2020 - 2025)

Historic Shares Outstanding (Weighted Average) for Ginkgo Bioworks Holdings (DNA) over the last 7 years, with Q3 2025 value amounting to $55.6 million.

  • Ginkgo Bioworks Holdings' Shares Outstanding (Weighted Average) rose 649.53% to $55.6 million in Q3 2025 from the same period last year, while for Sep 2025 it was $55.6 million, marking a year-over-year increase of 649.53%. This contributed to the annual value of $51.9 million for FY2024, which is 675.6% up from last year.
  • Ginkgo Bioworks Holdings' Shares Outstanding (Weighted Average) amounted to $55.6 million in Q3 2025, which was up 649.53% from $54.9 million recorded in Q2 2025.
  • Ginkgo Bioworks Holdings' 5-year Shares Outstanding (Weighted Average) high stood at $1.9 billion for Q2 2023, and its period low was $1.6 million during Q1 2022.
  • Over the past 5 years, Ginkgo Bioworks Holdings' median Shares Outstanding (Weighted Average) value was $54.9 million (recorded in 2025), while the average stood at $677.8 million.
  • In the last 5 years, Ginkgo Bioworks Holdings' Shares Outstanding (Weighted Average) crashed by 9987.54% in 2022 and then soared by 11902678.07% in 2023.
  • Quarter analysis of 5 years shows Ginkgo Bioworks Holdings' Shares Outstanding (Weighted Average) stood at $1.4 billion in 2021, then crashed by 96.91% to $42.0 million in 2022, then rose by 15.8% to $48.6 million in 2023, then rose by 6.76% to $51.9 million in 2024, then grew by 7.21% to $55.6 million in 2025.
  • Its Shares Outstanding (Weighted Average) stands at $55.6 million for Q3 2025, versus $54.9 million for Q2 2025 and $54.2 million for Q1 2025.